Johnson & Johnson Stock Forecast & Price Predictions for 2024, 2025–2026 and Beyond

June 10, 2024 10:19 am

Johnson & Johnson, a titan in the global healthcare industry, not only demonstrated its robust financial health with a 7.3% sales increase to $21.40 billion in the last quarter of 2023 but also reflected this strength in its stock performance. The company, known for its resilience and growth, reported a substantial net income of $4.13 billion, or $1.70 per share, making its stock a bellwether for the broader health sector and a reliable indicator for investors.

This article will provide an in-depth forecast for Johnson & Johnson’s stock as we look towards 2024 and beyond. We will offer valuable insights to help investors navigate the complexities of the healthcare market and make well-informed decisions about their investment in Johnson & Johnson’s promising future.

The article covers the following subjects:

Highlights and Key Points: JNJ stock Forecast 2024-2030

  • Johnson & Johnson is well-poised for a decade of growth and stability, thanks to its diversified healthcare businesses, strong finances, and promising drug pipeline. JNJ assets have consistently grown over the past decade, with projections extending until 2030. 
  • Analysts predict the stock could reach $164.77 per share by the end of 2024 with the lowest expected price of $40 and the most optimistic forecast of around $215.
  • Income-oriented investors are drawn to the company’s 60-year streak of dividend payments. JNJ’s pharmaceutical segment will strengthen with over 20 new drug launches by 2025. Its medical device and consumer health businesses provide reliable income streams. While the 2024 financial reports do not seem encouraging, the company still obtains upside potential.
  • Favorable demographic trends and JNJ’s defensive positioning drive demand for healthcare products and services. Analysts remain optimistic about JNJ assets over the next 7-10 years, foreseeing steady earnings and dividend increases. The healthcare giant’s diversification, strong fundamentals, and pipeline set the stage for a prosperous future.

JNJ Stock Price Today Coming Days and Week

When forecasting Johnson & Johnson’s stock for the coming days and weeks, focus on several key aspects. Analyze the company’s quarterly earnings reports for insights into revenue, profit margins, and future guidance. Pay attention to any news related to their pharmaceutical, medical device, and consumer health segments, as developments in these areas can significantly impact stock performance. Monitor market sentiment, influenced by analyst ratings and broader industry trends. Keep an eye on legal issues or regulatory changes, especially those affecting the healthcare sector. Additionally, consider macroeconomic factors like interest rates and overall market conditions, which can also affect stock prices.

Johnson & Johnson stocks: Summary

Johnson & Johnson is a world giant in the healthcare industry. The enterprise researches, develops, produces, and sells products in three key segments: Consumer Health, Pharmaceutical, and Medical Devices. Whenever you see the following brands, remember Johnson & Johnson is their parent company: Johnson’s, Aveeno, Acuvue, Listerine, Clean & Clear, Dr. Ci: Labo, Neutrogena, OGX, Tylenol, Benadryl, Zyrtec, Sudafed, Nicorette, Stayfree, Carefree, and many more.

Also, the company offers products in therapeutic areas such as immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases.

The Medical Devices segment includes a wide range of products that treat conditions such as hemorrhagic and ischemic stroke; support hips, knees, trauma, spine, sports; provide advanced and general surgery solutions with a focus on breast aesthetics, ear, nose, and throat procedures, as well as cataract and laser refractive surgery.

Here is some data on JNJ’s stocks (New York stock Exchange: JNJ):

  • Market cap: $353.45 billion;
  • Shares outstanding: 2.41 billion;
  • Public float: 2.40 billion;
  • P/E ratio: 9.72;
  • Payout ratio: 32.87% (in 2024);
  • Dividend yield: 3.38%;
  • Annual dividend: $4.96;
  • Forecast 12-month forward PEG Ratio: 0.89.

The enterprise was established in 1886 but only became a publicly traded company on September 24, 1944. Its shares are included in the S&P 500 and Dow Jones indices.

The current JNJ stock quote is $147.02.

Johnson & Johnson Stock Price Forecast for 2024 – Expert Predictions

Analysts are divided on JNJ’s price in 2024. Some predict that the stock will reach $$164.77 or higher due to a moderate revenue increase. Others assume that JNJ will close at $40, as there are no serious growth factors. Moreover, the stock has been in a downtrend for the past 52 weeks.


Price range for 2024: $40 – $215 (as for June 10, 2024)

StockAnalysis forecasts for Johnson & Johnson stock predict an average of $164.77. The lowest price is expected at $40 and the highest is $215. The overall outlook is bullish, but major fluctuations are expected.

Year Minimum price Average price Maximum price
2024 $40 $164.77 $215

30 Rates

Price range for 2024: $115.63 – $161.79 (as for June 10, 2024)

30Rates analysts estimate JNJ shares could drop to $130 by December 2024, continuing the downtrend.

Month Open, $ Low-High, $ Close, $
June 146.67 129.63-161.79 142.94
July 142.94 127.82-157.22 138.93
August 138.93 124.01-145.57 134.79
September 134.79 118.82-139.48 129.15
October 129.15 115.63-135.75 125.69
November 125.69 118.38-138.96 128.67
December 128.67 119.60-140.40 130.00


Price range for 2024: $145.689 – $149.969 (as for June 10, 2024)

WalletInvestor‘s technical analysis predicts that JNJ may trade around $148 by year-end.

Month Minimum price, $ Maximum price, $
July 148.864 149.934
August 148.047 149.969
September 146.274 147.894
October 145.689 146.726
November 146.687 147.386
December 147.363 147.884

Johnson & Johnson Technical Analysis

Johnson & Johnson is one of the longest-standing heavyweights in the healthcare industry. Shares of such companies can be easily analyzed by identifying cyclical patterns. When making a forecast, it is also important to evaluate the previous quarterly reports and how the oscillator data correlate with them. In order to analyze the stock performance, let’s use the classic SMA, RSI, and Ichimoku indicators, as well as Bollinger Bands.

Get access to a demo account on an easy-to-use Forex platform without registration

Go to Demo Account

#JNJ Stock Analysis For Next Three Months

Let’s use the D1 time frame to analyze #JNJ stock for the next three months. First of all, let’s take a look at the SMA and RSI indicators. The image below shows that the price is trading below the moving averages. The RSI is at 43.57, indicating that the asset is in the neutral zone.

Meanwhile, the price has reversed over the last three days. However, it will likely rebound from the resistance level at around $148.72. Let’s plot the Ichimoku indicator on the chart to get more market insights.

The Tenkan-sen line crosses the Kijun-sen line from above. The Tenkan-sen is moving downward, while the Kijun-sen is horizontal. The cloud is descending, and the instrument is trading below it. The Chikou span line is below the price level, preparing to breach it from below. The indicator generates a bearish signal.

Long-Term Johnson & Johnson Shares Technical Analysis for 2024

Considering the forecast for the next three months, it can be assumed that JNJ will continue declining in the long term if no fundamental data affects the price.

To forecast the JNJ price for 2024, let’s use Bollinger bands and Pivot Points. Below is a pessimistic scenario for the Johnson & Johnson stock price.

An optimistic forecast requires positive fundamental data. The asset may increase against a robust fundamental background, allowing the price to break through the resistance level of $148.

The table shows the likely minimum and maximum prices for each month of 2024 under an optimistic scenario:

Month Johnson & Johnson (#JNJ) Projected Price Values
Minimum Maximum
June $148.23 $150.98
July $149.99 $153.63
August $154.03 $157.44
September $156.61 $158.88
October $158.47 $160.33
November $161.82 $162.87
December $162.92 $164.76

Long-Term Trading Plan for Johnson & Johnson (#JNJ)

JNJ stock can hardly be considered a long-term investment now. Despite its growth potential, the asset needs a significant boost to reverse the current trend. These could be major news or a strong earnings report. However, it is unlikely that any of these events will occur shortly.

Based on the company’s long history and the fact that it is one of the oldest players in the market, a long-term investment in Johnson & Johnson stock is possible with sufficient margin. When making a plan, the following points should be taken into account:

  • Consider short trades in the coming month. Technical indicators point to a short-term decline;
  • A trend reversal is unlikely to occur shortly. However, when it comes to long-term investments, it makes sense to buy the stock if the price manages to breach the upper border of the channel around $148.72 in the next two months;
  • An optimistic assumes setting a target at $161.52;
  • A bearish outlook suggests a target near $140.52.

It is important to remember that market conditions can influence long-term predictions. Therefore, always conduct a comprehensive technical and fundamental analysis before making any trading decision.

Johnson & Johnson Stock Price Predictions for 2025

Johnson & Johnson (JNJ) exhibited robust performance and sustained growth in the past six years. However, the stock has recently sagged slightly. The COVID-19 pandemic has passed, so the entire healthcare industry faces a recession. New patents and innovations will determine the company’s growth.

Looking ahead to 2025, the asset is expected to trade between $148 and $201. Factors driving this positive outlook include new drug launches, post-COVID recovery in medical device sales, and consistent dividend increases. JNJ offers stability and substantial upside potential, making it an attractive investment opportunity.


Price range for 2025: $119.91 – $201.09 (as for June 10, 2024)

According to the 30Rates forecast for Johnson & Johnson (JNJ) stock in 2025, the financial trajectory is set to be quite positive. The year is projected to start with an opening price of $130. As we move through the year, the stock is expected to experience a progressive upward trend and rise to $186.19.

Month Opening, $ Min–Max, $ Closing, $
January 130.00 119.91-140.77 130.34
February 130.34 127.72-149.94 138.83
March 138.83 129.17-151.63 140.40
April 140.40 130.12-152.74 141.43
May 141.43 131.73-154.65 143.19
June 143.19 134.42-157.80 146.11
July 146.11 139.05-163.23 151.14
August 151.14 144.95-170.15 157.55
September 157.55 148.73-174.59 161.66
October 161.66 149.14-175.08 162.11
November 162.11 154.67-181.57 168.12
December 168.12 168.12-201.09 186.19


Price range for 2025: $143.858 – $148.170 (as for June 10, 2024)

According to the WalletInvestor forecast for JNJ stock in 2025, the financial trajectory appears fluctuating. The year is expected to commence with an opening price of $147.758 setting a moderately strong base. As the year progresses, JNJ’s stock price is projected to experience fluctuations, but overall, it shows a tendency towards gradual growth. This trend culminates in August with a closing price of $146.311, but at year’s end we will likely see slight yet strong bearish movement to $145.942.

Month Minimum, $ Maximum, $
January 146.549 147.827
February 145.108 146.223
March 144.589 145.241
April 145.513 147.146
May 145.661 147.155
June 145.426 147.063
July 147.177 148.094
August 146.311 148.170
September 144.578 146.128
October 143.858 144.934
November 144.851 145.510
December 145.489 146.081

Johnson & Johnson Stock Price Predictions for 2026

Johnson & Johnson’s market performance in 2026 is a troubled water, with price targets ranging from $144 to $181 by the end of that year.


Price range for 2026: $156 – $249 (as for June 10, 2024)

In 2026, according to LongForecast, the JNJ stock is expected to start the year at a pretty high level, approximately $182. As the year progresses, there is a clear upward trend in both the minimum and maximum prices, suggesting growing investor confidence or positive market influences on the stock. The average price gradually increases, reaching its peak in the later months. At the year’s second half, however, it is expected that JNJ stock will drop to the levels below the beginning of the year.

Month Opening, $ Min–Max, $ Closing, $
January 182 163-191 177
February 177 156-184 170
March 170 167-197 182
April 182 177-207 192
May 192 180-212 196
June 196 189-221 205
July 205 205-249 231
August 231 180-231 196
September 196 175-205 190
October 190 167-197 182
November 182 163-191 177
December 177 167-195 181


Price range for 2026: $142.042 – $146.371 (as for June 10, 2024)

According to WalletInvestor, in 2026 the JNJ stock is not showing any signs of strong movement. The asset is expected to stay between $142.042 and $146.371.

Date Minimum, $ Maximum, $
January 144.853 146.010
February 143.335 144.515
March 142.771 143.610
April 143.654 145.310
May 143.896 145.346
June 143.629 145.390
July 145.345 146.306
August 144.221 146.371
September 142.866 144.370
October 142.042 143.070
November 143.006 143.637
December 143.863 144.273

Johnson & Johnson Price History

Price history provides a critical context for predicting a stock’s future direction. For Johnson & Johnson (JNJ), the overall uptrend has been intact since 2012, with the assets reaching an all-time high of $171 in May 2021. 

However, JNJ has faced volatility along the way related to litigation issues. In 2018, the shares plunged on lawsuits alleging its baby talcum powder caused cancer, resulting in a $4.7 billion court-ordered payment. Though JNJ appealed, the negative headlines weighed on shares. In 2019 and 2020, further legal woes ensued around opioids and asbestos claims, which periodically pressured the shares. However, JNJ’s strong fundamentals, pharmaceutical pipeline, and work on a COVID-19 vaccine enabled the shares to recover from temporary dips. 

Despite setbacks like discarded doses of its vaccine in 2021, JNJ shares have shown resilience. The shares reached new highs above $180 in late 2022, reflecting the company’s diversified healthcare businesses and innovation driving consistent growth. While legal and headline risks remain, JNJ has proven its ability to power through challenges while rewarding long-term shareholders. Its cost history highlights a capacity to generate sustainable gains over time.

Long Term Johnson & Johnson Predictions 2027-2030

In the dynamic landscape of global healthcare and pharmaceuticals, Johnson & Johnson stands as a colossus with a legacy of innovation and resilience. As we gaze towards the horizon of 2027 to 2030, the company faces an intriguing interplay of challenges and opportunities. Let’s dive into the details.


Price range: $190 – $275 (as for June 10, 2024)

According to CoinPriceForecast, Johnson & Johnson (JNJ) stock is projected to experience significant growth between 2027 and 2030. The stock is expected to reach $193 at the end of 2027 and rise to $275 in the following three years.

Year Mid-Year Year-End Change, %
2027 $190 $193 +31%
2028 $212 $219 +49%
2029 $237 $252 +71%
2030 $269 $275 +87%


Price range: $139.977 – $143.047 (as for June 10, 2024)

WalletInvestor gives conservative forecasts. The price is unlikely to exhibit significant changes without the influence of fundamental factors.

Year Minimum, $ Average, $ Maximum, $
2027 141,805 142,426 143,047
2028 139,977 140,617 141,257

Factors that Can Affect the Johnson & Johnson stock price

Share performance factors include earnings reports, company events, industry news, and global market conditions. Let’s analyze Johnson & Johnson’s shares outlook:

  • Vaccine. J&J’s vaccine collaborations faced manufacturing challenges but rebounded after a brief decline due to FDA concerns. Their strong position as a vaccine producer suggests continued share cost growth.
  • Lawsuits. Talcum powder cancer cases since 2018 have impacted J&J shares due to its subsidiaries’ involvement, making future cases likely.
  • Strategy. J&J’s innovation focus and investments drive significant sales, attracting investors through popular brand subsidiaries.
  • Revenue. Consistently beating market expectations in quarterly revenue bolsters the stock’s resilience, making a decline unlikely.

Conclusion: are Johnson & Johnson Stocks a Good Investment?

Johnson & Johnson, a renowned global brand, is among the elite “Dividend Kings,” with an impressive record of raising dividends for over 50 consecutive years. JNJ stocks are well-suited for long-term investment. However, it’s important to note that the stock market is inherently volatile, and investing in shares requires due diligence and a solid risk management strategy. 

Furthermore, you can explore stock trading opportunities with a LiteFinance demo account, offering a variety of trading instruments and technical indicators to help you build your expertise.

FAQ’s on Johnson & Johnson stock forecast

Price chart of JNJ in real time mode

The content of this article reflects the author’s opinion and does not necessarily reflect the official position of LiteFinance. The material published on this page is provided for informational purposes only and should not be considered as the provision of investment advice for the purposes of Directive 2004/39/EC.

Rate this article:

{{value}} ( {{count}} {{title}} )

Feed from

MoneyMaker FX EA Trading Robot